Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Gary I, Sinclair"'
Autor:
Ricky K Hsu, John Phoenix, Gary I Sinclair, Samir K Gupta, Ana Puga, Kaitlin Nguyen, Catherine K Schubert, Deanna Merrill, David Richardson, Kate Nelson, Maria Reynolds, Laurie Zografos, Ashley Jean-Louis, Cindy Garris
Publikováno v:
Open Forum Infectious Diseases. 9
Background CAB+RPV LA is a complete regimen for treatment of virologically suppressed people with HIV (PWH). As an injectable therapeutic administered by a healthcare provider (HCP), CAB+RPV LA may alleviate challenges with adherence to daily oral th
Autor:
Cindy P, Garris, Maggie, Czarnogorski, Marybeth, Dalessandro, Ronald, D'Amico, Toyin, Nwafor, Will, Williams, Deanna, Merrill, YuanYuan, Wang, Larissa, Stassek, Michael B, Wohlfeiler, Gary I, Sinclair, Leandro A, Mena, Blair, Thedinger, Jason A, Flamm, Paul, Benson, William R, Spreen
Publikováno v:
Journal of the International AIDS Society. 25
The CUSTOMIZE hybrid III implementation-effectiveness study evaluated implementation of once-monthly long-acting (LA) cabotegravir + rilpivirine in diverse US healthcare settings. Here, we report patient participant perspectives after 12 months in CU
Autor:
Sorana, Segal-Maurer, Edwin, DeJesus, Hans-Jurgen, Stellbrink, Antonella, Castagna, Gary J, Richmond, Gary I, Sinclair, Krittaecho, Siripassorn, Peter J, Ruane, Mezgebe, Berhe, Hui, Wang, Nicolas A, Margot, Hadas, Dvory-Sobol, Robert H, Hyland, Diana M, Brainard, Martin S, Rhee, Jared M, Baeten, Jean-Michel, Molina, Mohammed, Rassool
Publikováno v:
The New England journal of medicine. 386(19)
Patients with multidrug-resistant human immunodeficiency virus type 1 (HIV-1) infection have limited treatment options. Lenacapavir is a first-in-class capsid inhibitor that showed substantial antiviral activity in a phase 1b study.In this phase 3 tr
Autor:
Maggie Czarnogorski, Cindy P. Garris, Marybeth Dalessandro, Ronald D'Amico, Toyin Nwafor, Will Williams, Deanna Merrill, YuanYuan Wang, Larissa Stassek, Michael B. Wohlfeiler, Gary I. Sinclair, Leandro A. Mena, Blair Thedinger, Jason A. Flamm, Paul Benson, William R. Spreen
Publikováno v:
Journal of the International AIDS Society. 25(9)
CUSTOMIZE evaluated the implementation of long-acting (LA) cabotegravir + rilpivirine, a novel healthcare provider-administered injectable antiretroviral therapy regimen, in diverse US healthcare settings. Findings from staff-study participants (SSPs
Autor:
Qi Liu, Chien-Hung Chou, Eda Canales, Roman Sakowicz, Steven Bondy, Tomas Cihlar, Albert Liclican, Diana M. Brainard, Anita Niedziela-Majka, William Rowe, Nikolai Novikov, Shekeba Ahmadyar, John R. Somoza, Randall L. Halcomb, Cheryl K. McDonald, Carina E. Cannizzaro, Nicolas Margot, Debi Jin, George Stepan, Qiaoyin Wu, Eric Hu, Judy Mwangi, Stephanie A. Leavitt, Todd C. Appleby, Robert L. Anderson, Scott E. Lazerwith, Schroeder Scott D, Tse Winston C, Gediminas Brizgys, Rebecca Begley, Yili Xu, Scott Sellers, Scott A. Wolckenhauer, Wesley I. Sundquist, Derek Hansen, Philip Morganelli, Andrew Mulato, Sheila Clancy, Xiaohong Liu, Anna Chiu, Eric S. Daar, Renee R. Ram, S. Swaminathan, Anne E. Chester, Melanie H. Wong, Ya-Pei Liu, John O. Link, Michael Graupe, Luong K. Tsai, Christian Callebaut, Latesh Lad, William E. Lee, Rujuta A. Bam, Terrence Z. Cai, Bing Lu, John K. Ling, Roland D. Saito, Magdeleine Hung, Armando G. Villaseñor, Peter Ruane, Nikos Pagratis, Martin S. Rhee, David Koditek, Gordon Crofoot, Giuseppe A. Papalia, Stephen R. Yant, Rob Hyland, Helen Yu, Jim Zheng, Jennifer R. Zhang, Gary I. Sinclair, Jiayao Li, Eric Singer
Publikováno v:
Nature
Oral antiretroviral agents provide life-saving treatments for millions of people living with HIV, and can prevent new infections via pre-exposure prophylaxis1–5. However, some people living with HIV who are heavily treatment-experienced have limite
Autor:
Colleen A. McHorney, Paul Wannamaker, William V. Williams, Larissa Stassek, Carolyn Selenski, Cindy Garris, Leandro Mena, Gary I Sinclair, Maggie Czarnogorski, Michael Wohlfeiler, Ronald D’Amico, David Margolis
Publikováno v:
Open Forum Infectious Diseases
Background CAB+RPV LA administered monthly for HIV treatment is non-inferior to daily oral ART at maintaining HIV suppression but concerns about implementation of this novel treatment paradigm remain. CUSTOMIZE, an implementation-effectiveness study,
Autor:
Jason Gillman, Sumihiro Suzuki, Gary I Sinclair, Lauren Rogers, Deanna Jody Rogers, Patrick G. Clay, Gene Voskuhl, Jialiang Liu
Publikováno v:
Open Forum Infectious Diseases. 3
Publikováno v:
Journal of HIV/AIDS & Social Services. 5:73-88
Resource poor regions, medically underserved by most measures, face particularly difficult challenges with regard to maintaining an adequate pool of HIV-competent physicians, physician assistants, and nurse practitioners. This paper describes a proje
Autor:
Keith B. Armitage, Gary I. Sinclair
Publikováno v:
Handbook of Rural Health ISBN: 9781441933478
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da9e0a515853cf2028240e00104998b1
https://doi.org/10.1007/978-1-4757-3310-5_10
https://doi.org/10.1007/978-1-4757-3310-5_10
Publikováno v:
Clinical Infectious Diseases. 29:223-224